Case study · Life sciences
A 2% cut in cost of goods, with analysis in days instead of weeks
2%lower COGS
- Life sciences
- Sourcing
About
A global biopharmaceutical company that develops and markets innovative drugs, relying heavily on contract manufacturers and under pressure from drug-price negotiations and tariffs.
Long-range planning left out contracts and financials. Planning, sourcing and finance weren't aligned, and scenarios took a lot of manual work across spreadsheets and fragmented tools that were prone to data errors.
The pharma and bio manufacturing network in EO Decision Engine with regulatory, supplier contract, capacity and financial constraints, set to minimize cost. Contract terms and renewals are part of the model, along with demand swings, new product launches and supply disruptions.
A 2% reduction in cost of goods sold. Analysis run time went from weeks to days, scenario preparation hours fell by half, and business users now run their own scenarios instead of waiting on specialists.
- Food and beverage
- Manufacturing
$5Min profit
Up to $5M in profit improvements from two of its five models
Fortune 1000 food and beverage maker
Read →- Logistics
- Network design
5–15%lower transport cost
Two facilities out of the network and 5–15% off transportation
Pitney Bowes
Read →- Consumer goods
- Capacity
$332Ksaved per week
$332K a week in savings by making fewer products at each plant
North American snack-food manufacturer
Read →
